Patents by Inventor David Bernard Boyle

David Bernard Boyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7276242
    Abstract: The invention relates to a fowl pox virus encoding an HIV antigen (gag and/or pol) and a cytokine (?-interferon).
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: October 2, 2007
    Assignee: Virax Immunotherapeutics Pty Ltd.
    Inventors: Stephen Kent, Ian Allister Ramshaw, David Bernard Boyle
  • Patent number: 7037712
    Abstract: A genome of an ovine adenovirus designated OAV287 is isolated from sheep and sequenced. Portions of the genome not essential for maintenance or viability of the virus can be deleted or altered. A nucleotide sequence encoding a non-adenoviral polypeptide can be incorporated into the genome. The a full-length clone of the genome can be provided as part of a plasmid or viral vector. Cells can be transformed with a vector of the invention such that they express an exogenous protein.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: May 2, 2006
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Gerald Wayne Both, David Bernard Boyle, Sadhanshu Vrati
  • Publication number: 20020045249
    Abstract: A genome of an ovine adenovirus designated OAV287 is isolated from sheep and sequenced. Portions of the genome not essential for maintenance or viability of the virus can be deleted or altered. A nucleotide sequence encoding a non-adenoviral polypeptide can be incorporated into the genome. The a full-length clone of the genome can be provided as part of a plasmid or viral vector. Cells can be transformed with a vector of the invention such that they express an exogenous protein.
    Type: Application
    Filed: December 16, 1999
    Publication date: April 18, 2002
    Inventors: GERALD WAYNE BOTH, DAVID BERNARD BOYLE, SUDHANSHU VRATI
  • Patent number: 5866131
    Abstract: A recombinant vaccine comprises a vaccine vector which incorporates a first nucleotide sequence capable of being expressed as all or a part of an antigenic polypeptide, together with a second nucleotide sequence capable of being expressed as all or a part of a lymphokine effective in enhancing the immune response to the antigenic polypeptide. The vaccine vectors include poxvirus, herpes virus or adenovirus, and the lymphokine may be an interleukin, tumour necrosis factor or gamma-interferon. The vaccine vector may express an antigenic polypeptide which is foreign to the host vector.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 2, 1999
    Assignees: Commonwealth Scientific and Industrial Research Organisation, The Australian National University
    Inventors: Ian Allister Ramshaw, David Bernard Boyle, Barbara Elizabeth Howieson Coupar, Marion Elizabeth Andrew
  • Patent number: 5866136
    Abstract: A recombinant vaccine comprises a vaccine vector which incorporates a first nucleotide sequence capable of being expressed as all or a part of an antigenic polypeptide, together with a second nucleotide sequence capable of being expressed as all or a part of a lymphokine effective in enhancing the immune response to the antigenic polypeptide. The vaccine vectors include poxvirus, herpes virus or adenovirus, and the lymphokine may be an interleukin, tumour necrosis factor or gamma-interferon. The vaccine vector may express an antigenic polypeptide which is foreign to the host vector.
    Type: Grant
    Filed: November 9, 1990
    Date of Patent: February 2, 1999
    Assignees: Commonwealth Scientific and Industrial Organisation, The Australian National University
    Inventors: Ian Allister Ramshaw, David Bernard Boyle, Barbara Elizabeth Howieson Coupar, Marion Elizabeth Andrew